Increased expression of the TGF-b superfamily cytokine MIC-1/GDF15 protects ApoE-/- mice from the development of atherosclerosis

被引:81
作者
Johnen, Heiko [1 ]
Kuffner, Tamara [1 ]
Brown, David A. [1 ]
Wu, Ben J. [2 ]
Stocker, Roland [2 ]
Breit, Samuel N. [1 ]
机构
[1] St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia
[2] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2050, Australia
基金
英国医学研究理事会;
关键词
MIC-1; GDF15; ApoE(-/-) mouse model of atherosclerosis; Atherosclerosis pathogenesis; MACROPHAGE INHIBITORY CYTOKINE-1; GROWTH-DIFFERENTIATION FACTOR-15; ACUTE CORONARY SYNDROME; BETA SUPERFAMILY; CANCER; RISK; DIAGNOSIS; MARKER;
D O I
10.1016/j.carpath.2012.02.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: MIC-1/GDF15 is a member of the TGF-b superfamily, which is thought to have pleiotropic roles in stress responses, inflammation, tissue injury and repair, energy homeostasis, and malignancy. MIC-1/GDF15 was recently identified as a new biomarker for the development of cardiovascular events and the outcome of atherosclerotic disease therapy. The aim of our study was to determine if MIC-1 also directly exerts pro- or antiatherogenic properties during the development of atherosclerosis. Methods and results: We investigated the effect of transgenic overexpression of MIC-I in macrophages in the ApoE(-/-) mouse model of atherosclerosis. After 6 months of high-fat diet, MIC-1/GDF 15 transgenic ApoE(-/-) mice had smaller atherosclerotic lesions; however, no differences in lesion composition, pro- or anti-inflammatory cytokine production, or serum levels of lipids or cytokines were detected. Conclusions: Our results suggest that MIC-1 has an overall protective effect on the disease process, but further studies will be required to define its mechanism of action. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:499 / 505
页数:7
相关论文
共 19 条
  • [1] Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer
    Bauskin, Asne R.
    Brown, David A.
    Kuffner, Tamara
    Johnen, Heiko
    Luo, X. Wei
    Hunter, Mark
    Breit, Samuel N.
    [J]. CANCER RESEARCH, 2006, 66 (10) : 4983 - 4986
  • [2] MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily
    Bootcov, MR
    Bauskin, AR
    Valenzuela, SM
    Moore, AG
    Bansal, M
    He, XY
    Zhang, HP
    Donnellan, M
    Mahler, S
    Pryor, K
    Walsh, BJ
    Nicholson, RC
    Fairlie, WD
    Por, SB
    Robbins, JM
    Breit, SN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (21) : 11514 - 11519
  • [3] The TGF-β superfamily cytokine, MIC-1/GDF15: A pleotrophic cytokine with roles in inflammation, cancer and metabolism
    Breit, Samuel N.
    Johnen, Heiko
    Cook, Andrew D.
    Tsai, Vicky W. W.
    Mohammad, Mohammad G.
    Kuffner, Tamara
    Zhang, Hong Ping
    Marquis, Christopher P.
    Jiang, Lele
    Lockwood, Glen
    Lee-Ng, Michelle
    Husaini, Yasmin
    Wu, Liyun
    Hamilton, John A.
    Brown, David A.
    [J]. GROWTH FACTORS, 2011, 29 (05) : 187 - 195
  • [4] Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis
    Brown, DA
    Stephan, C
    Ward, RL
    Law, M
    Hunter, M
    Bauskin, AR
    Amin, J
    Jung, K
    Diamandis, EP
    Hampton, GM
    Russell, PJ
    Giles, GG
    Breit, SN
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (01) : 89 - 96
  • [5] Brown DA, 2003, CLIN CANCER RES, V9, P2642
  • [6] Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study
    Brown, DA
    Breit, SN
    Buring, J
    Fairlie, WD
    Bauskin, AR
    Liu, T
    Ridker, PM
    [J]. LANCET, 2002, 359 (9324) : 2159 - 2163
  • [7] Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis - A potential marker of erosive joint destruction
    Brown, David A.
    Moore, John
    Johnen, Heiko
    Smeets, Tom J.
    Bauskin, Asne R.
    Kuffner, Tamara
    Weedon, Helen
    Milliken, Samuel T.
    Tak, Paul P.
    Smith, Malcolm D.
    Breit, Samuel N.
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (03): : 753 - 764
  • [8] Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis
    de Jager, Saskia C. A.
    Bermudez, Beatriz
    Bot, Ilze
    Koenen, Rory R.
    Bot, Martine
    Kavelaars, Annemieke
    de Waard, Vivian
    Heijnen, Cobi J.
    Muriana, Francisco J. G.
    Weber, Christian
    van Berkel, Theo J. C.
    Kuiper, Johan
    Lee, Se-Jin
    Abia, Rocio
    Biessen, Erik A. L.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (02) : 217 - 225
  • [9] Growth- Differentiation Factor-15 for Long-Term Risk Prediction in Patients Stabilized After an Episode of Non-ST-Segment-Elevation Acute Coronary Syndrome
    Eggers, Kai M.
    Kempf, Tibor
    Lagerqvist, Bo
    Lindahl, Bertil
    Olofsson, Sylvia
    Jantzen, Franziska
    Peter, Timo
    Allhoff, Tim
    Siegbahn, Agneta
    Venge, Per
    Wollert, Kai C.
    Wallentin, Lars
    [J]. CIRCULATION-CARDIOVASCULAR GENETICS, 2010, 3 (01) : 88 - U284
  • [10] Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1
    Johnen, Heiko
    Lin, Shu
    Kuffner, Tamara
    Brown, David A.
    Tsai, Vicky Wang-Wei
    Bauskin, Asne R.
    Wu, Liyun
    Pankhurst, Greg
    Jiang, Lele
    Junankar, Simon
    Hunter, Mark
    Fairlie, W. Douglas
    Lee, Nicola J.
    Enriquez, Ronaldo F.
    Baldock, Paul A.
    Corey, Eva
    Apple, Fred S.
    Murakami, MaryAnn M.
    Lin, En-Ju
    Wang, Chuansong
    During, Matthew J.
    Sainsbury, Amanda
    Herzog, Herbert
    Breit, Samuel N.
    [J]. NATURE MEDICINE, 2007, 13 (11) : 1333 - 1340